SCHEMBL2185969

SCHEMBL2185969

O=C(NCCc1cccc(Cl)c1)c1csc(CN(Cc2ccc(OC(F)(F)F)cc2)C(=O)O)n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 4/20 0.59
HIF1A Q16665 2/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
HTT P42858 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
GCGR P47871 1/20 0.42
GIPR P48546 1/20 0.42
CNR1 P21554 1/20 0.42
IGF1R P08069 1/20 0.42
CSNK1D P48730 1/20 0.42
MAPT P10636 2/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12407047 0.86 TRPV1 (0.61) TRPV1HIF1ASMN1; SMN2HTTNPC1
Hydrochloric Acid SCHEMBL2173185 0.86 TRPV1 (0.60) TRPV1HIF1ASMN1; SMN2HTTNPC1
SCHEMBL2173461 0.84 TRPV1 (0.58) TRPV1HIF1ASMN1; SMN2HTTNPC1
SCHEMBL283213 0.83 TRPV1 (0.58) TRPV1HIF1ASMN1; SMN2HTTNPC1
SCHEMBL2171406 0.77 SMN1; SMN2 (0.57) TRPV1HIF1ASMN1; SMN2HTTNPC1
SCHEMBL5670028 0.76 IGF1R (0.56) HIF1ASMN1; SMN2HTTNPC1RAB9A
Hydrochloric Acid SCHEMBL2173104 0.76 SMN1; SMN2 (0.56) TRPV1HIF1ASMN1; SMN2HTTNPC1
SCHEMBL2171648 0.76 TRPV1 (0.56) TRPV1HIF1ASMN1; SMN2HTTNPC1
SCHEMBL2173445 0.75 TRPV1 (0.53) TRPV1HIF1ASMN1; SMN2HTTNPC1
SCHEMBL2186611 0.74 TRPV1 (0.48) TRPV1SMN1; SMN2HTTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973061-B2 Anaplastic lymphoma kinase modulators and methods of use EXELIXIS, INC. (US) 2011-07-05 US disclosed